Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA

doi:10.3748/wjg.v10.i3.427

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8070)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

737

HTML

6396

Figures (1-2)

428

Tables (1-4)

509

Sum=8070

Feb 1, 2004 (publication date) through Oct 31, 2025

Times Cited of This Article

Times Cited (133)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Reports

World J Gastroenterol. Feb 1, 2004; 10(3): 427-432
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.427

Open in New Tab Full Size Figure Download Figure

Figure 1 Mean serum CA19-9 and CEA concentrations. ^aP < 0.001, ^bP < 0.05 vs benign biliary diseases or healthy individuals. ^cP < 0.05 vs serum CEA.

Open in New Tab Full Size Figure Download Figure

Figure 2 Mean postoperative serum CA19-9 and CEA levels of resectable group and mean serum CA19-9 and CEA levels of the unresectable group.

Citation: Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA. World J Gastroenterol 2004; 10(3): 427-432
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/427.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i3.427